期刊文献+

新型噁唑烷酮类化合物5-位侧链的结构改造及抗菌活性 被引量:1

Modification of novel oxazolidinone derivatives at C-5 side chain and their antibacterial activities
下载PDF
导出
摘要 目的对嗯唑烷酮类化合物5-位侧链进行结构修饰与改造,并初步评价其体外抗菌活性。方法以间氟苯胺为原料,经9~12步反应合成目标化合物;采用二倍稀释法,测定目标化合物的体外抗菌活性。结果设计、合成了30个新化合物,其中目标化合物18个,其结构经^1H NMR及MS等方法确证,11个化合物显示出不同程度的抗菌活性,化合物7a,9a和11a的活性较好。结论化合物7a,9a和11a值得进一步研究。 Aim To modify the C-5 side chains vitro antibacterial activities preliminarily. Methods of the oxazolidinone derivatives and evaluate their in The title compounds were synthesized in 9 - 12 steps with the starting material 3-fluoroaniline and their in vitro antibacterial activities were examined by using Mueller-Hinton broth dilution method. Results Thirty new compounds were designed and synthesized, in which eighteen novel title compounds were prepared and their structures were confirmed by ^1H NMR and ESI-MS. Eleven compounds showed antibacterial activities to a certain extent, among them compounds 7a, 9a and lla displayed promising activity. Conclusion Compounds 7a, 9a and lla were worth further studying.
出处 《药学学报》 CAS CSCD 北大核心 2006年第10期985-989,共5页 Acta Pharmaceutica Sinica
关键词 嗯唑烷酮类化合物 5-位侧链 抗菌活性 合成 oxazolidinone derivatives C-5 side chains antibacterial activities synthesis
  • 相关文献

参考文献11

  • 1Abbanat D,Macielag M,Bush K.Novel antibacterial agents for the treatment of serious Gran-positive infections[J].Expert Opin Investig Drugs,2003,12:379-399.
  • 2Spellberg B,Powers JH,Brass EP,et al.Trends in antimicrobial drug development:implications for the future[J].Clin Infect Dis,2004,38:1279-1286.
  • 3Aoki H,Ke L,Poppe SM,et al.Oxazolidinone antibiotics target the P site on escherichia coli ribosomes[J].Antimicrob Agents Chemother,2002,46:1080 -1085.
  • 4Barbachyn MR,Ford CW.Oxazolidinone structureactivity relationships leading to linezolid[J].Angew Chem Int Ed,2003,42:2010-2023.
  • 5Li Z,Willke RJ,Pinto LA,et al.Comparison of length of hospital stay for patients with known or suspected methicillin-resistant Staphylococcus species infections treated with linezolid or vancomycin:a randomized,multicenter trial[J].Pharmacotherapy,2001,21:263 -274.
  • 6Gonzales RD,Schreckenberger PC,Graham MB,et al.Infections due to vancomycin-resistant Enterococcus faecium resistant to linezolid[J].Lancet,2001,357:1179.
  • 7Tokuyama R,Takahashi Y,Tomita Y,et al.Structureactivity relationship (SAR) studies on oxazolidinone antibacterial agents.1.Conversion of 5-substituent on oxazolidinone[J].Chem Pharm Bull,2001,49:347-352.
  • 8郝金恒,翟鑫,袁立,黄亮,王志谦,刘亚婧,宫平.新型噁唑烷酮类化合物的全合成及抗菌活性研究[J].中国药物化学杂志,2005,15(2):76-79. 被引量:3
  • 9Wang CJ,Gregory WA,Wuonola.Chiral synthesis of DUP721,a new antibacterial agent[J].Tetrahedron,1989,45:1323-1326.
  • 10Bentley TJ,Asato G.Anthranilonitrile derivatives and related compounds as useful agents for promoting growth,improving feed efficiency,and for increasing the lean meat to fat ratio of warm-blooded animals:US,86114149.7[P],1987-06-03.

二级参考文献8

  • 1Fines M, Leclercq R. Activity of linezolid against grampositive cocci possessing genes conferring resistance to protein synthesis inhibitors[J]. J Antimicrob Chemother, 2000, 45 (6):797 - 802.
  • 2Eustice DC, Feldman PA, Zajac I, et al. Mechanism of action id DUP 721:inhibition of an early event during initiation of protein synthesis [J]. Antimicrob Agents Chemother, 1998, 42(5): 1217 - 1221.
  • 3Natesan S, Deekonda S, Manoj KK, et al. Synthesis of conformationally constrained analogues of linezolid:structure-activity relationship(SAR)studies on selected novel tricyclic oxazolidinones[J]. J Med Chem, 2002,45 (18): 3953 - 3962.
  • 4Steven JB, Douglas KH, Michael RB, et al. Synthesis and antibacterial activity of U-100592 and U-100766,two oxazolidinone antibacterial agents for the potential treatment of multidrug-resistant gram-positive bacterial infection[J]. J Med Chem, 1996, 39 (3): 673-679.
  • 5Bentley TJ, Asato G. Anthranilonitrile derivatives and related compounds as useful agents for promotion growth, improving feed efficiency, and for increasing the lean meat to fat ratio of warm-blooded animals[P]. EP:02240011 A1, 1986 - 10 - 13.
  • 6Jacgues J, Marguet A. Selective α-bromination of an aralkyl ketone with phenyltrimethylammonium tribromide: 2-bromoacetyl-6-methoxynaphthalene and 2, 2-dibromoacetyl-6-methoxynaphthalene [J]. Org Syn,1973, 53:111.
  • 7郑卫.抗细菌药物研究的新进展[J].国外医药(抗生素分册),2000,21(2):57-63. 被引量:19
  • 8马翔,周伟澄.新型全合成抗菌药噁唑烷酮类化合物的研究进展[J].中国医药工业杂志,2000,31(8):370-376. 被引量:13

共引文献2

同被引文献8

  • 1赵燕芳,洪伟,柴慧芳,董金华,宫平.5-羟基-1 H-吲哚-3-羧酸乙酯类化合物的合成及其抗流感病毒活性[J].中国药物化学杂志,2004,14(4):219-224. 被引量:5
  • 2LIN A H, MURRAY R W, VIDMAR T J, et al. The oxazolidinone eperezolid binds to the 50s ribosomal subunit and competes with binding of chloramphenicol and lincomycin [ J ]. Antimicrob Agents Chemother, 1997, 41(10) :2127 - 2131.
  • 3HIRSCHL A M, APFALTER P, MAKRISTATHIS A, et al. In vitro activities of linezolid along and in combination with amoxlciUin , clarithromycin, and metronidazole against Helicobacter pylori [J]. Antimicrob Agents Chemother, 2000, 44 (7) : 1977 - 1979.
  • 4FINES M, LECLERCQ R. Activity of linezolid against gram-positive coci possessing genes conferring resistance to protein synthesis inhibitors [ J ]. J Antimicrob Chemother, 2000, 45 (6) : 797 - 802.
  • 5GREGORY W A, BRITTELLI D R, WANG C L J, et al. Antibacterials synthesis and structure-activity studies of 3-aryl-2-oxazolidinones. 1. The "A" group[J]. J Med Chem, 1990, 33(9) :2569 - 2578.
  • 6HESTER J B. Oxazolidinones thioamides with piperazine amide substituents: WO, 0058885 [ P]. 2001 - 08 - 20.
  • 7ASHOK RATTAN. Oxazolidinone antibacterial RBx- 7644[J]. Drugs Fut, 2003, 28(11) : 1070 - 1077.
  • 8张胜权,吕利英,张书利,艾林.噁唑烷酮类抗菌药的研究进展[J].国外医药(抗生素分册),2004,25(1):34-42. 被引量:9

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部